计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| A127488-5mg |
5mg |
现货 ![]() |
| |
| A127488-10mg |
10mg |
现货 ![]() |
| |
| A127488-25mg |
25mg |
现货 ![]() |
| |
| A127488-50mg |
50mg |
现货 ![]() |
| |
| A127488-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | NSC799339 | NSC-799339 | AKOS016006006 | 1-cyclopropyl-3-[(3Z)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea | AT 9283 [WHO-DD] | HMS3673I15 | 35R | A900407 | HMS3244P09 | TIAMULIN [INN] | 1-cyclopropyl-3-[3-(5-morpholin- |
|---|---|
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | AT9283 |
| 生化机理 | AT9283 可抑制 HCT116 细胞中极光 B 激酶的活性,导致明显的多倍体表型,IC50 为 30 nM。此外,AT9283 还能有效抑制 HCT116 细胞的集落形成。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 酪氨酸蛋白激酶 JAK3 抑制剂 |
| 产品介绍 |
AT9283是多靶点抑制剂,对Bcr-Abl(T3151),Jak2,Jak3,aurora A和B的IC50分别为4,1.2,1.1,3 nM和3 nM。 AT9283 is a small molecule a multi-targeted inhibitor with IC50s of 4, 1.2, 1.1 and approximate 3 nM for Bcr-Abl(T3151), JAK2 and JAK3, Aurora A and Aurora B, respectively. |
| 纯度 | ≥98% |
| ALogP | 0.5 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504773220 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | 1-cyclopropyl-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea |
| INCHI | 1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27) |
| InChi Key | LOLPPWBBNUVNQZ-UHFFFAOYSA-N |
| Smiles | C1CC1NC(=O)NC2=C(NN=C2)C3=NC4=C(N3)C=C(C=C4)CN5CCOCC5 |
| Isomeric SMILES | C1CC1NC(=O)NC2=C(NN=C2)C3=NC4=C(N3)C=C(C=C4)CN5CCOCC5 |
| 分子量 | 381.43 |
| Reaxy-Rn | 36407987 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=36407987&ln= |
| 溶解性 | DMSO ≥73mg/mL Water <1.2mg/mL Ethanol ≥25mg/mL |
|---|---|
| 分子量 | 381.400 g/mol |
| XLogP3 | 0.500 |
| 氢键供体数Hydrogen Bond Donor Count | 4 |
| 氢键受体数Hydrogen Bond Acceptor Count | 5 |
| 可旋转键计数Rotatable Bond Count | 5 |
| 精确质量Exact Mass | 381.191 Da |
| 单同位素质量Monoisotopic Mass | 381.191 Da |
| 拓扑极表面积Topological Polar Surface Area | 111.000 Ų |
| 重原子数Heavy Atom Count | 28 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 554.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Howard S, Berdini V, Boulstridge JA, Carr MG, Cross DM, Curry J, Devine LA, Early TR, Fazal L, Gill AL et al.. (2009) Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity.. J Med Chem, 52 (2): (379-88). [PMID:19143567] |